Meeder Asset Management’s Idexx Laboratories IDXX Stock Holding History

Meeder Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$84.8K	Buy	151 +25	+20%	+$16K	﹤0.01%	384
2025 Q4	$85.2K	Buy	126 +107	+563%	+$72.9K	﹤0.01%	348
2025 Q3	$12.1K	Hold	19	–	–	﹤0.01%	516
2025 Q2	$10.2K	Sell	19 -6,144	-100%	-$2.94M	﹤0.01%	611
2025 Q1	$2.59M	Buy	6,163 +6,135	+21,911%	+$2.66M	0.17%	82
2024 Q4	$11.6K	Sell	28 -151	-84%	-$66.2K	﹤0.01%	665
2024 Q3	$90.4K	Buy	179 +154	+616%	+$74.8K	0.01%	302
2024 Q2	$12.2K	Buy	25 +1	+4%	+$502	﹤0.01%	609
2024 Q1	$13K	Buy	+24	New	+$13.1K	﹤0.01%	511
2023 Q3	–	Sell	-4,842	Closed	-$2.43M	–	535
2023 Q2	$2.43M	Buy	4,842 +1,906	+65%	+$913K	0.18%	114
2023 Q1	$1.47M	Buy	2,936 +1,534	+109%	+$734K	0.12%	143
2022 Q4	$572K	Sell	1,402 -201	-13%	-$78K	0.05%	240
2022 Q3	$521K	Sell	1,603 -3,003	-65%	-$1.1M	0.03%	371
2022 Q2	$1.61M	Buy	4,606 +3,408	+284%	+$1.39M	0.09%	179
2022 Q1	$655K	Buy	1,198 +1,194	+29,850%	+$628K	0.03%	348
2021 Q4	$3K	Sell	4 -1,817	-100%	-$1.14M	﹤0.01%	935
2021 Q3	$1.13M	Buy	1,821 +864	+90%	+$581K	0.06%	252
2021 Q2	$604K	Sell	957 -4,407	-82%	-$2.43M	0.03%	412
2021 Q1	$2.62M	Buy	5,364 +4,753	+778%	+$2.38M	0.13%	149
2020 Q4	$305K	Sell	611 -1,748	-74%	-$782K	0.07%	235
2020 Q3	$928K	Buy	2,359 +1,999	+555%	+$739K	0.06%	248
2020 Q2	$119K	Sell	360 -1,364	-79%	-$395K	0.01%	731
2020 Q1	$417K	Buy	1,724 +1,333	+341%	+$348K	0.03%	375
2019 Q4	$102K	Sell	391 -3,689	-90%	-$972K	0.01%	786
2019 Q3	$1.11M	Buy	4,080 +898	+28%	+$250K	0.07%	221
2019 Q2	$875K	Sell	3,182 -5,176	-62%	-$1.28M	0.06%	268
2019 Q1	$1.87M	Buy	8,358 +856	+11%	+$177K	0.15%	128
2018 Q4	$1.4M	Sell	7,502 -1,772	-19%	-$363K	0.12%	149
2018 Q3	$2.31M	Buy	9,274 +8,188	+754%	+$1.99M	0.17%	127
2018 Q2	$237K	Buy	1,086 +728	+203%	+$150K	0.02%	487
2018 Q1	$69K	Hold	358	–	–	0.01%	609
2017 Q4	$56K	Sell	358 -1,327	-79%	-$209K	﹤0.01%	661
2017 Q3	$262K	Sell	1,685 -5,453	-76%	-$862K	0.03%	438
2017 Q2	$1.15M	Sell	7,138 -11,870	-62%	-$1.93M	0.11%	178
2017 Q1	$2.94M	Sell	19,008 -2,616	-12%	-$361K	0.26%	87
2016 Q4	$2.54M	Buy	21,624 +12,574	+139%	+$1.43M	0.24%	101
2016 Q3	$1.02M	Buy	+9,050	New	+$954K	0.09%	248

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meeder Asset Management's IDXX Position: Q1 2026 in Review

Meeder Asset Management increased its Idexx Laboratories (IDXX) stake by 20% in Q1 2026, buying an estimated $16K and bringing the position to 151 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Meeder Asset Management first reported a position in IDXX in Q3 2016 and has held it in 37 quarters since. The position peaked at $2.94M in Q1 2017. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Meeder Asset Management held 151 shares of Idexx Laboratories worth $84.8K as of Q1 2026.
Meeder Asset Management bought 25 Idexx Laboratories shares in Q1 2026, an estimated $16K.
Idexx Laboratories made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #384 holding.
Meeder Asset Management first reported a position in Idexx Laboratories in Q3 2016 and has held it in 37 quarters since.
Meeder Asset Management's Idexx Laboratories position peaked at $2.94M in Q1 2017.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.